The role of pharmacogenetics in the treatment of chronic hepatitis C infection.
about
Recent advances in management of the HIV/HCV coinfected patient.PharmGKB summary: peginterferon-α pathway.Provision of clinical pharmacist services for individuals with chronic hepatitis C viral infection: Joint Opinion of the GI/Liver/Nutrition and Infectious Diseases Practice and Research Networks of the American College of Clinical Pharmacy.A systematic review and meta-analysis of HCV clearance.Pharmacogenetics of ribavirin-induced anemia in HCV patients.Ribavirin at the Era of Novel Direct Antiviral Agents for the Treatment of Hepatitis C Virus Infection: Relevance of Pharmacological Monitoring
P2860
The role of pharmacogenetics in the treatment of chronic hepatitis C infection.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The role of pharmacogenetics in the treatment of chronic hepatitis C infection.
@en
type
label
The role of pharmacogenetics in the treatment of chronic hepatitis C infection.
@en
prefLabel
The role of pharmacogenetics in the treatment of chronic hepatitis C infection.
@en
P2860
P356
P1433
P1476
The role of pharmacogenetics in the treatment of chronic hepatitis C infection.
@en
P2093
Marina Kawaguchi-Suzuki
P2860
P304
P356
10.1002/PHAR.1349
P407
P577
2013-09-30T00:00:00Z